Publication
International Restructuring Newswire
Welcome to the Q2 2024 edition of the Norton Rose Fulbright International Restructuring Newswire.
Global | Publication | April 2018
This year, Canada’s federal government laid out plans to legalize the sale of adult use cannabis. If this legislation passes, Canada will be the largest developed nation to end the prohibition on cannabis. With the imminent shift, there are many new opportunities for businesses operating across the industry.
We have worked with clients operating under the medical cannabis regime, and are working with companies in identifying risks and preparing for opportunities emerging from the newly-proposed adult use cannabis regime. We have extensive experience and a proven track record in providing strategic guidance to companies at the preliminary licensing stage, through expansion and diversification of their cannabis-related portfolios.
Our lawyers have a deep understanding of the existing and emerging cannabis industries enabling us to provide our clients with practical commercial, regulatory and strategic advice. We have advised key industry players across the value chain, including producers, investors, research and developers and technology providers.
Corporate and commercial – We advise on equity and debt financings, private placements, initial public offerings, corporate governance, electronic commerce and Internet agreements, equity compensation plans and tax planning, as well as on strategic partnerships, joint ventures and mergers and acquisitions within the industry (domestic and cross-border).
Compliance, regulation and licensing – We advise on the regulation of medical cannabis, licenses under the Access to Cannabis for Medical Purposes Regulations (ACMPR) regime, Health Canada compliance and standard operating procedures, privacy and data protection, as well as on security requirements for growth and distribution facilities. We have in-depth knowledge of the Controlled Drugs and Substances Act, the ACMPR and the Narcotic Control Regulations, as well as the proposed Cannabis Act, and regularly advise clients on the requirements of these regulatory regimes.
Commercialization and licensing – We advise on agreements that will assist our clients in bringing their innovations and products to market from licencing arrangements to distribution and supply agreements. We have significant experience related to cross-border licensing for cannabis-based products and supply agreements.
Intellectual property – We advise on patent applications relating to wide variety of cannabis-related innovation, including covering the systems and procedures associated with planting, growing, harvesting, processing, diagnostics and delivery mechanisms of cannabis. We are also experienced in drafting and negotiating licenses for cannabis-related intellectual property, as well as providing strategic advice for the branding of cannabis products and services, including managing and securing branding portfolios, and all aspects of social media and domain names. We have advised on the protection and filings related to Plant Breeders’ Rights.
Publication
Welcome to the Q2 2024 edition of the Norton Rose Fulbright International Restructuring Newswire.
Publication
On 16 April 2024, the Hon Tanya Plibersek MP, the Minister for the Environment and Water (the Minister) announced progress on the package of reforms to the Environment Protection and Biodiversity Conservation Act 1999 (Cth) (EPBC Act).
Publication
The DOJ Criminal Division’s Pilot Program on Voluntary Self-Disclosure for Individuals aims to encourage individuals with potential criminal exposure to voluntarily disclose corporate criminal conduct in exchange for discretionary grants of immunity.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023